Company Reports

Amplifon reported 4.7% organic sales growth in the second quarter, a significant step up from the previous quarter and the highest in two years. Adjusted EBITDA rose 6.1%, with margin expanding to 25.1%. Management maintained its full-year guidance.

Amplifon is the global leader in hearing care retail, operating an extensive network of over 10,000 points of sale across 26 countries. With the announced acquisition of GN's hearing business, Amplifon is shifting its strategy from a pure-play retailer to a vertically integrated manufacturer, like its peers Demant and Sonova.

Amplifon posted first-quarter results with 2.2% organic sales growth and a record adjusted EBITDA margin of 24.5%, driven by the Fit4Growth initiative. Management clarified its 2026 guidance, now explicitly targeting above 3% organic sales growth.

Amplifon is the global leader in hearing care retail, operating an extensive network of over 10,000 points of sale across 26 countries. With the announced acquisition of GN's hearing business, Amplifon is shifting its strategy from a pure-play retailer to a vertically integrated manufacturer, like its peers Demant and Sonova.

Amplifon is the global leader in hearing care retail, operating an extensive network of over 10,000 points of sale across 26 countries. With the announced acquisition of GN's hearing business, Amplifon is shifting its strategy from a pure-play retailer to a vertically integrated manufacturer, like its peers Demant and Sonova.

We reviewed Amplifon following its agreement to acquire GN Store Nord’s hearing business. Since the announcement, the share price has fallen by over 20%, reflecting market skepticism.

GN Store Nord is divesting its hearing division to Amplifon for DKK 17 billion in a cash-and-stock deal. GN will receive roughly 16% of Amplifon’s shares. Shares of GN are trading 25% higher intraday, and Amplifon's shares are 8% lower.

Amplifon reported 1.4% constant-currency sales growth in the fourth quarter of 2025; full-year growth of 1.7% met its company-compiled target. Management expects markets to stabilize in 2026, with growth of around 3%.

Amplifon is the global leader in hearing care retail, operating an extensive network of over 10,000 stores. It operates a pure-play retail and service model, focusing exclusively on audiological consultation, customized fittings, and device distribution.

Amplifon is the global leader in hearing care retail, operating an extensive network of over 10,000 points of sale across 26 countries. Unlike its primary listed competitors, such as Sonova and Demant, Amplifon does not manufacture hearing devices. Instead, it operates a pure-play retail and service model, focusing exclusively on audiological consultation, customized fitting, and device distribution. This brand-agnostic approach is a differentiator to hybrid business models, as it positions Amplifon as an objective advisor capable of offering customers a diverse range of technological solutions tailored to their specific needs.